Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-03-27

FDA Approved: ESCITALOPRAM — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' supplemental application for a generic escitalopram product (ANDA 078169).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Escitalopram (escitalopram)

Snippet

SUPPL AP for ESCITALOPRAM (ESCITSLOPRAM)